Sex-regulated gene dosage effect of PPARα on synaptic plasticity
暂无分享,去创建一个
I. Dewachter | B. Staels | J. Brion | D. Tyteca | K. Leroy | L. Ris | P. Gailly | J. Octave | Nathalie Pierrot | P. Kienlen-Campard | O. Schakman | E. Baugé | F. Lalloyer | Liza Malong | I. Stancu | Anna Doshina | Floriane Ribeiro
[1] for the Alzheimer’s Disease Neuroimaging Initiative,et al. Sex differences in Alzheimer disease — the gateway to precision medicine , 2018, Nature Reviews Neurology.
[2] H. Chung,et al. Impairment of PPARα and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging. , 2018, Journal of the American Society of Nephrology : JASN.
[3] S. Yamashita,et al. Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial , 2018, Diabetes Care.
[4] B. Zlokovic,et al. Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.
[5] N. Inestrosa,et al. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation , 2017, Biological reviews of the Cambridge Philosophical Society.
[6] S. Yamashita,et al. Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial. , 2017, Journal of clinical lipidology.
[7] S. Moreno,et al. Targeting PPARalpha in Alzheimer's Disease. , 2017, Current Alzheimer research.
[8] I. Dewachter,et al. Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission , 2017, Scientific Reports.
[9] G. Landreth,et al. Therapeutic potential of nuclear receptor agonists in Alzheimer’s disease , 2017, Journal of Lipid Research.
[10] G. Landreth,et al. Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease , 2017, Scientific Reports.
[11] Laura B. Ferguson,et al. Localization of PPAR isotypes in the adult mouse and human brain , 2016, Scientific Reports.
[12] B. Staels,et al. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis. , 2016, Atherosclerosis.
[13] H. Offner,et al. Sex differences and the role of PPAR alpha in experimental stroke , 2016, Metabolic Brain Disease.
[14] J. Schug,et al. RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers , 2016, Scientific Reports.
[15] R. Lhommel,et al. Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.
[16] Danko D. Georgiev,et al. Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity , 2015, The Journal of Neuroscience.
[17] T. Kodama,et al. Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver. , 2015, Journal of atherosclerosis and thrombosis.
[18] L. Garcia-Segura,et al. Signaling mechanisms mediating the regulation of synaptic plasticity and memory by estradiol , 2015, Hormones and Behavior.
[19] F. Gonzalez,et al. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP , 2015, Proceedings of the National Academy of Sciences.
[20] R. Citraro,et al. Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice , 2015, Molecular metabolism.
[21] R. Evans,et al. Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.
[22] J. Kordower,et al. Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α. , 2013, Cell reports.
[23] L. Ris,et al. Improved preparation and preservation of hippocampal mouse slices for a very stable and reproducible recording of long-term potentiation. , 2013, Journal of visualized experiments : JoVE.
[24] M. D’Amelio,et al. CREB is necessary for synaptic maintenance and learning‐induced changes of the ampa receptor GluA1 subunit , 2013, Hippocampus.
[25] Jean-Baptiste Demoulin,et al. Amyloid precursor protein controls cholesterol turnover needed for neuronal activity , 2013, EMBO molecular medicine.
[26] M. W. Wooten,et al. Isolation and culture of hippocampal neurons from prenatal mice. , 2012, Journal of visualized experiments : JoVE.
[27] M. Hofker,et al. Peroxisome Proliferator–Activated Receptor-&agr; Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[28] Philippe Lefebvre,et al. Retinoid X receptors: common heterodimerization partners with distinct functions , 2010, Trends in Endocrinology & Metabolism.
[29] S. Ingrand,et al. Gender-dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease , 2010, Neurobiology of Aging.
[30] K. J. Murphy,et al. Discrimination of cell types in mixed cortical culture using calcium imaging: A comparison to immunocytochemical labeling , 2008, Journal of Neuroscience Methods.
[31] Peter Tontonoz,et al. Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.
[32] B. Staels,et al. Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists. , 2007, Bioorganic & medicinal chemistry letters.
[33] Graham L. Collingridge,et al. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions , 2007, Journal of Neuroscience Methods.
[34] T. Soderling,et al. Regulatory mechanisms of AMPA receptors in synaptic plasticity , 2007, Nature Reviews Neuroscience.
[35] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[36] R. Evans,et al. Anatomical Profiling of Nuclear Receptor Expression Reveals a Hierarchical Transcriptional Network , 2006, Cell.
[37] R. W. Draft,et al. Restoration of spatial working memory by genetic rescue of GluR-A–deficient mice , 2005, Nature Neuroscience.
[38] M. Febbraio,et al. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. , 2004, Journal of molecular endocrinology.
[39] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[40] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] J Auwerx,et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. , 1998, Circulation.
[42] R. Heyman,et al. Transactivation by Retinoid X Receptor–Peroxisome Proliferator-Activated Receptor γ (PPARγ) Heterodimers: Intermolecular Synergy Requires Only the PPARγ Hormone-Dependent Activation Function , 1998, Molecular and Cellular Biology.
[43] M. Kennedy,et al. A Synaptic Ras-GTPase Activating Protein (p135 SynGAP) Inhibited by CaM Kinase II , 1998, Neuron.
[44] M. Leid,et al. p300 Functions as a Coactivator for the Peroxisome Proliferator-activated Receptor α* , 1997, The Journal of Biological Chemistry.
[45] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[46] J. Tata. Autoregulation and crossregulation of nuclear receptor genes , 1994, Trends in Endocrinology & Metabolism.
[47] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[48] A. Riecher-Rössler. Sex and gender differences in mental disorders. , 2017, The lancet. Psychiatry.
[49] B. Staels,et al. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD , 2017, Nature Reviews Endocrinology.
[50] William Bourguet,et al. Modulation of RXR function through ligand design. , 2012, Biochimica et biophysica acta.
[51] M. Febbraio,et al. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. , 2004, Journal of molecular endocrinology.
[52] W. Wahli,et al. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. , 2003, Endocrinology.
[53] R. Heyman,et al. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function. , 1998, Molecular and cellular biology.